Eliquis receives ‘positive opinion’ from EMA

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended an addition to the current Summary of Product Characteristics (SmPC) and stated that ‘Patients can stay on apixaban while being cardioverted.’
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: Cardiovascular medicine apixaban ARISTOTLE Eliquis Latest News non-valvular atrial fibrillation stroke systemic embolism Source Type: news